| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | Australia | 4 | |
| #4 | Canada | 4 | |
| #5 | WIPO (World Intellectual Property Organization) | 4 | |
| #6 | Brazil | 2 | |
| #7 | China | 2 | |
| #8 | Hong Kong | 2 | |
| #9 | Israel | 2 | |
| #10 | Mexico | 2 | |
| #11 | Singapore | 2 | |
| #12 | Hungary | 1 | |
| #13 | India | 1 | |
| #14 | Republic of Korea | 1 | |
| #15 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Beyrath Julien David | 24 |
| #2 | Smeitink Johannes Albertus Maria | 22 |
| #3 | Leenders Ruben Gerardus George | 8 |
| #4 | Sterk Geert Jan | 8 |
| #5 | Hermkens Pedro Harold Han | 8 |
| #6 | Blaauw Richard Hendrik | 8 |
| #7 | Julien David Beyrath | 6 |
| #8 | Johannes Albertus Maria Smeitink | 6 |
| #9 | Van Zandvoort Petrus Maria | 4 |
| #10 | Pellegrini Mina | 4 |
| Publication | Filing date | Title |
|---|---|---|
| SG11202003806WA | Novel compounds for use in treating depression and migraine | |
| WO2019101826A1 | Compounds as mpges-1 inhibitors | |
| EP3606522A1 | Novel treatment of mitochondrial diseases | |
| WO2017060432A1 | Novel compounds for treating mitochondrial disease | |
| EP2872497A1 | Chromanyl derivatives for treating mitochondrial disease | |
| US2015166501A1 | Chromanyl derivatives for treating mitochondrial disease |